Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
European Journal of Clinical Pharmacology|January 7, 2015
Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadolTuukka Saarikoski, Teijo I Saari, Nora M Hagelberg, et al.
Pharmacogenetics and Genomics|May 3, 2005
Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17Mikko Niemi, Pertti J Neuvonen, Ute Hofmann, et al.
Clinical Science (London, England : 1979)|February 17, 2017
Simvastatin pre-treatment improves survival and mitochondrial function in a 3-day fluid-resuscitated rat model of sepsisJerome Morel, Iain Hargreaves, David Brealey, et al.
Pharmacology Research & Perspectives|January 19, 2017
Rifampicin decreases exposure to sublingual buprenorphine in healthy subjectsNora M Hagelberg, Mari Fihlman, Tuija Hemmilä, et al.
Clinical and Translational Science|May 27, 2020
Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate RosuvastatinMinna Lehtisalo, Jenni E Keskitalo, Aleksi Tornio, et al.
Journal of Clinical Pharmacology|October 7, 2020
Relationship of Edoxaban Plasma Concentration and Blood Coagulation in Healthy Volunteers Using Standard Laboratory Tests and Viscoelastic AnalysisMartina Havrdová, Teijo I Saari, Jouko Jalonen, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast PharmacokineticsPäivi Hirvensalo, Aleksi Tornio, Mikko Neuvonen, et al.
European Journal of Clinical Pharmacology|September 1, 2018
Voriconazole greatly increases the exposure to oral buprenorphineMari Fihlman, Tuija Hemmilä, Nora M Hagelberg, et al.
Clinical Pharmacology and Therapeutics|June 18, 2005
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokineticsMikko Niemi, Janne T Backman, Lauri I Kajosaari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 2024
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in HumansMikael O W Piha, Kristiina Cajanus, Marica T Engström, et al.
Pageof 16